Peptide GLP-1 receptor agonists: From injection to oral delivery strategies.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Peptide GLP-1 receptor agonists: From injection to oral delivery strategies.
- Published In:
- Biochemical pharmacology, 229, 116471 (2024)
- Authors:
- Ke, Zhiqiang, Ma, Qianqian, Ye, Xiaonan, Wang, Yanlin, Jin, Yan, Zhao, Xinyuan, Su, Zhengding
- Database ID:
- RPEP-08535
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08535APA
Ke, Zhiqiang; Ma, Qianqian; Ye, Xiaonan; Wang, Yanlin; Jin, Yan; Zhao, Xinyuan; Su, Zhengding. (2024). Peptide GLP-1 receptor agonists: From injection to oral delivery strategies.. Biochemical pharmacology, 229, 116471. https://doi.org/10.1016/j.bcp.2024.116471
MLA
Ke, Zhiqiang, et al. "Peptide GLP-1 receptor agonists: From injection to oral delivery strategies.." Biochemical pharmacology, 2024. https://doi.org/10.1016/j.bcp.2024.116471
RethinkPeptides
RethinkPeptides Research Database. "Peptide GLP-1 receptor agonists: From injection to oral deli..." RPEP-08535. Retrieved from https://rethinkpeptides.com/research/ke-2024-peptide-glp1-receptor-agonists
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.